Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: KHS who wrote (19985)	3/22/1999 8:59:00 PM
From: John M. Gelnieau	Read Replies (2) \| Respond to of 23519

Hey folks, I know this is blind faith but something with great potential has to be up for U.S.. After all, who in hell would found a company, develop products, spend millions on R&D, and then not go to market and sell the damn thing. This is VVUS today with MUSE in U.S.. There is little if any incremental cost to market/sell/detail MUSE for an organization that has a product line already in place with big client base. With that in mind scripts will surely grow. Look at recent script numbers. By all right there should be none and there are still over 3,000/week. I sense there is a big plan, that hopefully to god Leland is not in charge of executing, in which a number of powerful positioning factors come togehter that will dramatically impact sales of MUSE in the U.S.. VVUS does not need 30% marketshare to make tens of millions of dollars from ED. Just my current thinking FWIW.